Liqun Wang, PhD

Principal Scientist, Brain Targeting Program at Wyss Institute at Harvard University

Speaker

Dr. Wang has more than 15 years academic and industry experience in neuroscience, neurodegenerative diseases, assay development, in vivo pharmacology and product development. She currently leads antibody brain shuttle discovery and development efforts in Wyss Institute’s Brain Targeting Program.